The RECOVER IV Trial

Stopped Given the findings from the DanGer Shock RCT, the RECOVER IV independent DSMB believes that equipoise for randomization in the RECOVER IV Trial no longer exists and has recommended that the RECOVER IV Trial be permanently discontinued.

Conditions

• ST-segment Elevation Myocardial Infarction (STEMI)
• Cardiogenic Shock

Interventions

• DEVICE: Impella CP®
• OTHER: Standard of Care

Sponsor

Abiomed Inc.